Spasticity: Clinical Trials

6 trials for Spasticity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Unknown 2

Follow Spasticity: new trials by email Literature Review of Spasticity trials Research Report on Spasticity

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings
Botulinum neurotoxin (BTX), Physical Therapy, Standard BTX injection (ultrasound guided) - Spasticity
Phase 4CompletedThe University of Texas Health Science Center, Houston172017-11-212020-11-05
Upper Extremity Rehabilitation Using Robot and Botulinum Toxin
Early Inmotion and Botox, Botox, then Inmotion, Inmotion, then Botox - Stroke, Spasticity
Phase 4UnknownNational Rehabilitation Center, Seoul, Korea3482014-03-012014-08-29
Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke
Tenotomy of the proximal rectus femoris tendon, Botulinum Toxin injection in the rectus femoris muscle - Stroke, Spasticity
Phase 4UnknownUniversity Hospital of Mont-Godinne202014-03-012014-04-15
A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients
Sativex, Placebo - Multiple Sclerosis, Spasticity
Phase 4CompletedJazz Pharmaceuticals1212012-01-012023-01-12
Vanderbilt University Spasticity Management Program Evaluation Plan
Botulinum Toxin Type A, Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB) - Spasticity
Phase 4CompletedVanderbilt University202002-08-012007-08-20
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Botox - Stroke, Brain Injuries
Phase 4CompletedThe University of Texas Health Science Center, Houston332002-01-012021-01-22

Narrower conditions

Muscle Spasticity (6)  ·  Stroke (4)  ·  Brain Injuries (1)  ·  Developmental Disabilities (1)  ·  Multiple Sclerosis (1)

Broader conditions

Muscle Hypertonia (6)  ·  Muscular Diseases (6)  ·  Musculoskeletal Diseases (6)  ·  Nervous System Diseases (6)  ·  Neurologic Manifestations (6)  ·  Neuromuscular Manifestations (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Signs and Symptoms (6)  ·  Brain Diseases (4)  ·  Cardiovascular Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Cerebrovascular Disorders (4)  ·  Vascular Diseases (4)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)

Interventions

Botulinum Toxins, Type A (4)  ·  Botulinum Toxins (2)  ·  Physical Therapy Modalities (1)  ·  nabiximols (1)

Sponsors

The University of Texas Health Science Center, Houston (2)  ·  Jazz Pharmaceuticals (1)  ·  National Rehabilitation Center, Seoul, Korea (1)  ·  University Hospital of Mont-Godinne (1)  ·  Vanderbilt University (1)

Countries

United States (3)  ·  Belgium (1)  ·  Czechia (1)  ·  South Korea (1)

Top investigators

David Charles, MD (1)  ·  Gerard E Francisco, MD (1)  ·  Joon-Ho Shin, MS (1)  ·  Sheng Li, MD, PhD (1)  ·  Thierry Deltombe, M.D. (1)

Results publications

PMID 24151639, PMID 34532852, PMID 40050906